Panacea Life Sciences Holdings, Inc. Long-Term Debt, Maturity, after Year Five
Panacea Life Sciences Holdings, Inc. (PLSH) had Long-Term Debt, Maturity, after Year Five of $95.51 thousand as of 2021-03-31, per its 10-Q/A filed 2021-05-27.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2021-05-27
- 2021-03-31: Long-Term Debt, Maturity, after Year Five $95.51K; Long-Term Debt, Maturity, after Year Five as first filed $97.67K.
- 2020-12-31: Long-Term Debt, Maturity, after Year Five $97.67K.
- 2020-09-30: Long-Term Debt, Maturity, after Year Five $97.67K.
- 2020-06-30: Long-Term Debt, Maturity, after Year Five $97.67K.
| Period end | Long-Term Debt, Maturity, after Year Five | Long-Term Debt, Maturity, after Year Five as first filed |
|---|---|---|
| 2021-03-31 | $95.51K 10-Q/A · filed 2021-05-27 | $97.67K 10-Q · filed 2021-05-24 |
| 2020-12-31 | $97.67K 10-K/A · filed 2021-04-23 | |
| 2020-09-30 | $97.67K 10-Q · filed 2020-11-18 | |
| 2020-06-30 | $97.67K 10-Q · filed 2020-08-19 |